MYH9-related disease
MYH9-related disease
Speakers: Jose Rivera Pozo, Maria Luisa Lozano Almela
Dr. Jose Rivera Pozo obtained a degree in Chemistry at the University of Murcia in 1985 and a PhD in Biochemistry at the University of Valencia in 1990. Since 1991 he is member of the staff at the Blood Transfusion Centre of Murcia (CRH), where he is responsible of the Quality System and blood processing departments. Dr. River is also Associate Professor at the Department of Internal Medicine of the University of Murcia (Spain) and senior investigator of the Biomedical Research institute of Murcia (IMIB) and the Spanish Network of Rare Diseases (CIBERER).
At the CRH he leads the research areas of blood component processing as well as basic and clinical research in platelet physiology and pathology.
He has published around 150 articles in international peer-reviewed journals (Blood, JTH, T&H, Haematologica, Transfusion, Vox Sanguinis, Platelets, etc.), and presented more than 250 communications in national and international congresses (Index h:34, according to Scopus; h:41, according to Google Academico; 03/04/2023). His publications are available at https://orcid.org/0000-0003-4225-6840.
He has supervised twenty Doctoral and Master Thesis achieving maximal qualification and has gained several research prizes in Spain.
During this career, he has been the principal investigator in around twenty research projects granted by Public and private organizations, leading currently three of them.
In 2015-2019, he was one of the co-chairs of the Platelet Physiology Subcommittee of the International Society of Thrombosis and Hemostasis (ISTH). He is member of the ISTH, the Spanish Societies of Hematology (SEHH), Thrombosis & Haemostasis (SETH) and blood Transfusion (SETS), the Working Group on Blood Processing of the SETS, and the Platelet Disorders expert panel of CLinGen. Since 2008 he leads the Spanish Working Group on Diagnosis & Study of Inherited Platelet Disorders (GEAPC) and the Spanish Registry of Inherited Platelet Disorders (RETPLAC).
Nowadays, he has ongoing, multiple national and international research collaborations in the platelet field.
Dr. Maria L Lozano is associate Professor of Hematology at the University of Murcia, Attending Physician, and Head of the Hematology-Oncology Department at the Morales Meseguer Hospital, and Director of the Regional Blood Bank, Murcia, Spain and Member of Rare Diseases Networking Biomedical Research Centre (CIBERER).
Maria L Lozano attained her medical degree and Ph.D. from the University of Murcia and obtained a Post-doctoral Fulbright Fellowship at the Platelet Immunology Department from the Blood Research Institute (Milwaukee, WI). Professor Lozano's research interest lies in the area of inherited and acquired platelet disorders, and cellular therapy product collection and processing. She has been president of the executive committee of the Spanish ITP Group (2018-2021), and Co-PI of the project "Functional and Molecular Characterization of Patients with Inherited Platelet Disorders" under the scientific sponsorship of the Spanish Society of Thrombosis and Haemostasis. She is a founding member of the European Research Consortium on ITP (ERCI). Dr. Lozano has authored or co-authored more than 160 manuscripts published in international peer-reviewed journals, with more than 4000 citations (Hirsch´s index of 36).